文献速递中医内科中药与中成药合理使用

通心络胶囊:化学成分、药理作用、质量控制与临床应用综述

Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications.
PubMed 文献 · Phytomedicine · 2024-04-24

本文综述通心络胶囊(TXL)的化学成分、质量控制、药理特性、不良反应与临床应用;TXL治疗心脑血管疾病(CCVD)有效且不良反应较少,通过调节脂代谢、氧化应激与炎症等多条通路发挥作用,但仍需更多临床试验与动物实验提供证据。

要点

  • TXL治疗CCVD患者有效,且不良反应较少。
  • TXL通过脂代谢、氧化应激、炎症等多通路发挥抗CCVD作用。
  • 临床应用建议仍需更多临床试验与动物实验证据支持。

核心结论

  • TXL通过调节脂代谢、氧化应激和炎症等多条通路,在CCVD治疗中发挥关键作用。
  • TXL治疗CCVD患者有效且不良反应较少。
  • 仍需进一步临床试验和动物实验为其临床应用提供更多证据和建议。

研究设计与样本

  • 本文为综述,检索PubMed、Web of Science、Google Scholar、中国知网和万方数据库,检索截至2023年。
  • 检索关键词包括「TXL」「CCVD」「Chemical constituents」「Quality control」「Pharmacological properties」。
  • 综述过程遵循PRISMA指南。

主要发现

  • 研究证实TXL治疗CCVD患者有效,且不良反应较少。
  • 本综述从氧化应激、脂代谢和心功能改善角度探讨TXL的抗CCVD作用。
  • 综述还补充了TXL安全性相关信息。

临床怎么用

  • 可将TXL视为CCVD治疗中有前景的中药选择,关注其疗效与较少不良反应的特点。
  • 应用时需结合脂代谢、氧化应激与炎症等作用通路理解其潜在获益。

局限性

  • 仍需进一步临床试验和动物实验提供更多证据与推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular and cerebrovascular disease (CCVD) is the leading cause of morbidity and mortality worldwide, imposing a significant economic burden on individuals and societies. For the past few years, Traditional Chinese Medicine (TCM) has attracted much attention due to its advantages such as fewer side effects in the treatment of CCVD. TXL has shown great promise in the treatment of CCVD. PURPOSE: This paper aims to provide a comprehensive introduction to TXL, covering its chemical constituents, quality control, pharmacological properties, adverse reactions, and clinical applications through an extensive search of relevant electronic databases while discussing its current challenges and provides opinions for future study. METHODS: The following electronic databases were searched up to 2023: "TXL", "CCVD", "Chemical constituents", "Quality control" and "Pharmacological properties" were entered as keywords in PubMed, Web of Science, Google Scholar and China National Knowledge Infrastructure Database and WANFANG DATA databases. The PRISMA guidelines were followed in this review process. RESULTS: Studies have confirmed that TXL is effective in treating patients with CCVD and has fewer adverse effects. The aim of this review is to explore TXL anti-CCVD effects in relation to oxidative stress, lipid metabolism and enhanced cardiac function. This review also provides additional information on safety issues. CONCLUSION: TXL plays a key role in the treatment of CCVD by regulating various pathways such as lipid metabolism, oxidative stress and inflammation. However, further clinical trials and animal experiments are needed to provide more evidence and recommendations for its clinical application. This article provides an overview of TXL research to inform and inspire future studies.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Chen Q, Zou J, Shi Y, et al. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications. Phytomedicine. 2024. PMID: 38901283. doi:10.1016/j.phymed.2024.155674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。